Blog: Helsinki health tech startups reached a funding record in 2020, reports Juha Paakkola

Cutting-edge research

The mRNA technology that did an amazing market entry with COVID vaccines is a milestone in drug and treatment development for key areas like cancer and MS. The Helsinki ecosystem is in a good position to embrace this opportunity. Universities and the leading hospital HUS Helsinki University Hospital have strong genetics, oncology, neurology and immunology research. The FinnGen research is combining genetic and health data in a unique way – also contributing significantly to COVID-19 research.

If you wish to know more about top molecular medicine research conducted in Helsinki, you can join the webinar series presenting FIMM. The next event is on 22 June – welcome!

Service design adding value in healthcare

While generating new – even disrupting – innovations and solutions, we need to understand what is really needed and who needs it. We should develop solutions and services that are really adding value, reducing costs and improving quality of care. Patients’ and healthcare professionals’ insights are needed in the process and professional service design can add true value. In Finland, Aalto University and Haaga-Helia University of Applied Sciences are experts in service design.

Let’s get connected – the fall is filled with opportunities

The past 1,5 years have been tough for many of us. Let’s take a well-deserved break during the summer, relax and reload our batteries.

Next fall will be full steam ahead. We at Health Capital Helsinki are committed to supporting our startups and research community, large corporations and health stakeholders. Let’s get connected, innovate together, and find new solutions that are making a difference.

With these words, I wish you all a great, sunny and relaxing summer – see you soon!